Inhibition of mTOR-kinase destabilizes MYCN and is a potential therapy for MYCN-dependent tumors.

Oncotarget · 2016 · PMC5295370 · PMID 27438153

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

These results show a clear trend in drug sensitivity where inhibition of cell proliferation aligns with the degree of MYCN amplification and protein expression.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.